Cargando…
Advanced T and Natural Killer Cell Therapy for Glioblastoma
Although immunotherapy has been broadly successful in the treatment of hematologic malignancies and a subset of solid tumors, its clinical outcomes for glioblastoma are still inadequate. The results could be due to neuroanatomical structures such as the blood-brain-barrier, antigenic heterogeneity,...
Autores principales: | Yoon, Wan-Soo, Chung, Dong-Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurosurgical Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323271/ https://www.ncbi.nlm.nih.gov/pubmed/36588388 http://dx.doi.org/10.3340/jkns.2022.0267 |
Ejemplares similares
-
Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022) -
Natural Killer Cell-Based Immunotherapy against Glioblastoma
por: Morimoto, Takayuki, et al.
Publicado: (2023) -
Understanding of molecular mechanisms in natural killer cell therapy
por: Yoon, Suk Ran, et al.
Publicado: (2015) -
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
por: Lupo, Kyle B., et al.
Publicado: (2020) -
Natural killer cell-based therapies
por: Romagné, François, et al.
Publicado: (2011)